Back

Immunosuppressive therapy and prognosis in biopsy-proven fulminant lymphocytic myocarditis requiring veno-arterial extracorporeal membranous oxygenation support

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Diagnosis, management and prognosis in myocarditis Myocarditis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Takahiro Okumura

Fujita Health University, Toyoake (Japan)

4 More presentations in this session

Presentation thumbnail
Outcome of histologically-proven fulminant versus acute non-fulminant myocarditis with left ventricular systolic dysfunction. Evidence from the International Registry on Acute Myocarditis
Doctor E. Ammirati (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Familial cardiomyopathy in patients affected by acute myocarditis is strongly associated to DSP gene mutations
Doctor L. Marteau (Nantes, FR)
Abstract Slides Video
Presentation thumbnail
Long-term outcome of patients with biopsy-proven viral myocarditis: 12-year results from a late gadolinium enhancement cardiac magnetic resonance study
Mr A. Seitz (Stuttgart, DE)
Abstract
Presentation thumbnail
Evaluation of myocardial gene expression profiling for superior diagnosis of idiopathic giant cell myocarditis in a large cohort of patients with acute cardiac decompensation
Doctor F. Escher (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Diagnosis, management and prognosis in myocarditis

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources